Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-24

Clinical Trial Update: Scotoma Perimetry Oculomotor Training [NA]

View source ↗

Summary

The clinical trial evaluating Scotoma Perimetry Oculomotor Training for macular degeneration and central visual impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Macular Degeneration, Central Visual Impairment | NA | Status: COMPLETED